Cite
miR-708-5p promotes fibroblast-like synoviocytes' cell apoptosis and ameliorates rheumatoid arthritis by the inhibition of Wnt3a/β-catenin pathway.
MLA
Wu, Jie, et al. “MiR-708-5p Promotes Fibroblast-like Synoviocytes’ Cell Apoptosis and Ameliorates Rheumatoid Arthritis by the Inhibition of Wnt3a/β-Catenin Pathway.” Drug Design, Development and Therapy, vol. 12, Oct. 2018, pp. 3439–47. EBSCOhost, https://doi.org/10.2147/DDDT.S177128.
APA
Wu, J., Fan, W., Ma, L., & Geng, X. (2018). miR-708-5p promotes fibroblast-like synoviocytes’ cell apoptosis and ameliorates rheumatoid arthritis by the inhibition of Wnt3a/β-catenin pathway. Drug Design, Development and Therapy, 12, 3439–3447. https://doi.org/10.2147/DDDT.S177128
Chicago
Wu, Jie, Wenqiang Fan, Ling Ma, and Xiuqin Geng. 2018. “MiR-708-5p Promotes Fibroblast-like Synoviocytes’ Cell Apoptosis and Ameliorates Rheumatoid Arthritis by the Inhibition of Wnt3a/β-Catenin Pathway.” Drug Design, Development and Therapy 12 (October): 3439–47. doi:10.2147/DDDT.S177128.